Version anglaise seulement

Plant-based drugs present unusual challenges in the pharmaceutical world with respect to large-scale cultivation, processing, quality, and consistency. In the case of Cannabis sativa L., considerable additional complexity derives from regulatory concerns, depending on the coun-tries of production and marketing.